Skip to main content
Premium Trial:

Request an Annual Quote

Scimagix Moves into Europe; New MRC Spin-off Hires Orchid s Ashton as CEO

NEW YORK, Nov. 20-Scimagix said yesterday that it had expanded its European operations and added a new vice president of marketing, John Andrews.

 

The San Mateo, Calif.-based bioinformatics firm has opened new headquarters in Luton, England and sales and support offices in Munich, Germany and Paris, France in response to "growing demand" for its products in Europe, the company said.

 

Andrews will manage expansion in these new markets. He was previously executive vice president of field operations for Aurigin Systems, a patent information company. Prior to that, he was executive vice president of sales and marketing for Entelos.

 

The company also hired Bob Marchmont as Business Area Director for Proteomics. Marchmont, who was previously with Nonlinear Dynamics, will lead product marketing efforts for the company's ProteinMine line.

 


 

Psychiatric Genomics said yesterday that it had added Michael Knable to its scientific advisory board. Knable is medical director for the Stanley Medical Research Institute, which funds and conducts research on schizophrenia and bipolar disorder. Psychiatric Genomics has a research collaboration with the SMRI, and the institute also has invested in the company.

 

 


 

Chris Ashton has been appointed chief executive officer of the new British knockout mouse company Etiologics, the firm announced on Nov. 18.

 

Ashton, 42, was previously Vice President and Managing Director of European Operations at Orchid Biosciences, where he established and managed the company's European division. During this time, Ashton arranged the company's first major SNP genotyping deal and directed the acquisition of Cellmark Diagnostics from AstraZeneca.

 

Before joining Orchid in 2000, he was commercial director of Inpharmatica, the University College London bioinformatics spin-off.

 

Etiologics, based in Oxford, UK, develops and screens new knockout mice for use as disease models in drug discovery. It was spun out last month from the Medical Research Council Mammalian Genetics Unit.

 


 

Promoted? Changing jobs? GenomeWeb wants to know. E-mail Kathleen McGowan at [email protected] to appear in PEOPLE, a roundup of personnel comings and goings in genomics, that appears every Wednesday.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.